Drugs & Targets European Orphan Designations granted to CF102 and ENMD-2076 October 16, 2015Vol.41 No.38
Drugs & Targets Breakthrough Therapy Granted To Abemaciclib in Breast Cancer October 09, 2015Vol.41 No.37
Drugs & Targets MD Anderson and Theraclone Sciences launch OncoResponse company October 09, 2015Vol.41 No.37
Drugs & Targets FDA grants priority review to defibrotide for hepatic VOD October 02, 2015Vol.41 No.36
